J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed. Earlier, the board of directors of J. B. Chemicals & Pharmaceuticals had given approval for acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited.
Piramal Enterprises on Tuesday announced that the company's wholly owned subsidiary Piramal Capital & Housing Finance Limited has acquired 100 per cent stake in PRL Agastya Private Limited for a cash consideration ?90 crore.
The meeting of Administrative Committee of the Board of Directors of Piramal Enterprises Limited has approved allotment of 1,000 Secured, Rated, Listed, Redeemable Principal Protected, Market Linked Non-Convertible Debentures each having a face value of Rs. 10,00,000, at a further issue price of Rs. 10,39,670 per Debenture, aggregating to Rs. 103.967 crore on private placement basis.
MUMBAI, India, Nov. 9, 2022 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2022.
Piramal Pharma reports Q2 FY23 consolidated loss at Rs. 37.34 Cr
Piramal Pharma to inject funds into expansion, acquisitions
MUMBAI, Oct. 19, 2022 /PRNewswire/ -- Piramal Pharma Limited (PPL) (Scrip Name: PPLPHARMA) today listed on the Indian stock exchanges, Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). The milestone was marked with the ringing of the opening bell at BSE to announce the listing by Mr. Ajay Piramal, Chairman of Piramal Group, Ms. Nandini Piramal, Chairperson of PPL, and Mr. Peter DeYoung, CEO, Piramal Global Pharma, along with Mr. Nayan Mehta, Chief Financial Officer and Mr. Sameer Patil, Chief Business Officer from the Bombay Stock Exchange Ltd.
Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics
Piramal Pharma unveils its Sustainability Report FY21–22
Indian scientist and industrialist Swati Piramal conferred top French honour